SG11201900360TA - Therapeutic agent for glaucoma - Google Patents
Therapeutic agent for glaucomaInfo
- Publication number
- SG11201900360TA SG11201900360TA SG11201900360TA SG11201900360TA SG11201900360TA SG 11201900360T A SG11201900360T A SG 11201900360TA SG 11201900360T A SG11201900360T A SG 11201900360TA SG 11201900360T A SG11201900360T A SG 11201900360TA SG 11201900360T A SG11201900360T A SG 11201900360TA
- Authority
- SG
- Singapore
- Prior art keywords
- glaucoma
- therapeutic agent
- formula
- agent
- toa76
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 229940124597 therapeutic agent Drugs 0.000 title abstract 3
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016144392 | 2016-07-22 | ||
| PCT/JP2017/026391 WO2018016611A1 (ja) | 2016-07-22 | 2017-07-21 | 緑内障治療薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201900360TA true SG11201900360TA (en) | 2019-02-27 |
Family
ID=60993067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201900360TA SG11201900360TA (en) | 2016-07-22 | 2017-07-21 | Therapeutic agent for glaucoma |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10682323B2 (de) |
| EP (1) | EP3489219B1 (de) |
| JP (1) | JPWO2018016611A1 (de) |
| KR (1) | KR20190031207A (de) |
| CN (1) | CN109476589A (de) |
| AU (1) | AU2017300558B2 (de) |
| CA (1) | CA3031603A1 (de) |
| PH (1) | PH12019500082A1 (de) |
| RU (1) | RU2019104002A (de) |
| SG (1) | SG11201900360TA (de) |
| WO (1) | WO2018016611A1 (de) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5855479B2 (ja) | 2012-01-31 | 2016-02-09 | 株式会社アルバック | プラズマエッチング装置 |
| US9290440B2 (en) | 2012-04-16 | 2016-03-22 | Toa Eiyo Ltd. | Bicyclic compound |
| EP2875003B1 (de) | 2012-07-20 | 2016-11-16 | Bayer Pharma Aktiengesellschaft | Neue 5-aminotetrahydrochinolin-2-carbonsäuren und ihre verwendung |
| WO2014012935A1 (de) | 2012-07-20 | 2014-01-23 | Bayer Pharma Aktiengesellschaft | Substituierte aminoindan- und aminotetralin-carbonsäuren und ihre verwendung |
| US8951825B1 (en) | 2013-09-10 | 2015-02-10 | Palo Alto Research Center Incorporated | Solar cell texturing |
| JPWO2015056663A1 (ja) * | 2013-10-15 | 2017-03-09 | トーアエイヨー株式会社 | ４−アミノメチル安息香酸誘導体 |
| JP6210847B2 (ja) | 2013-11-11 | 2017-10-11 | 株式会社ディスコ | 切削装置及び切削方法 |
| WO2015095515A1 (en) | 2013-12-20 | 2015-06-25 | Novartis Ag | Sgc activators for the treatment of glaucoma |
| TW201625586A (zh) * | 2014-07-02 | 2016-07-16 | 諾華公司 | 環己烯－１－基－吡啶－２－基－１ｈ－吡唑－４－羧酸衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 |
| TW201625601A (zh) | 2014-07-02 | 2016-07-16 | 諾華公司 | 噻吩－２－基－吡啶－２－基－１ｈ－吡唑－４－羧酸衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 |
| TW201625584A (zh) | 2014-07-02 | 2016-07-16 | 諾華公司 | 茚滿及吲哚啉衍生物及其作為可溶性鳥苷酸環化酶活化劑之用途 |
-
2017
- 2017-07-21 WO PCT/JP2017/026391 patent/WO2018016611A1/ja unknown
- 2017-07-21 AU AU2017300558A patent/AU2017300558B2/en not_active Expired - Fee Related
- 2017-07-21 RU RU2019104002A patent/RU2019104002A/ru not_active Application Discontinuation
- 2017-07-21 CN CN201780044127.5A patent/CN109476589A/zh active Pending
- 2017-07-21 EP EP17831127.0A patent/EP3489219B1/de active Active
- 2017-07-21 US US16/317,921 patent/US10682323B2/en not_active Expired - Fee Related
- 2017-07-21 SG SG11201900360TA patent/SG11201900360TA/en unknown
- 2017-07-21 KR KR1020187037134A patent/KR20190031207A/ko not_active Application Discontinuation
- 2017-07-21 JP JP2018528883A patent/JPWO2018016611A1/ja not_active Withdrawn
- 2017-07-21 CA CA3031603A patent/CA3031603A1/en not_active Abandoned
-
2019
- 2019-01-11 PH PH12019500082A patent/PH12019500082A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3489219A4 (de) | 2020-02-26 |
| EP3489219A1 (de) | 2019-05-29 |
| PH12019500082A1 (en) | 2019-07-29 |
| CN109476589A (zh) | 2019-03-15 |
| US10682323B2 (en) | 2020-06-16 |
| JPWO2018016611A1 (ja) | 2019-05-09 |
| AU2017300558A1 (en) | 2019-01-31 |
| CA3031603A1 (en) | 2018-01-25 |
| KR20190031207A (ko) | 2019-03-25 |
| US20190231724A1 (en) | 2019-08-01 |
| EP3489219B1 (de) | 2020-12-16 |
| RU2019104002A3 (de) | 2020-08-24 |
| WO2018016611A1 (ja) | 2018-01-25 |
| AU2017300558B2 (en) | 2021-02-25 |
| RU2019104002A (ru) | 2020-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2017176957A8 (en) | Mdm2 protein degraders | |
| MX2022012317A (es) | Oxisteroles y metodos de uso de los mismos. | |
| MX2023001876A (es) | Derivados de rapamicina. | |
| MX2023005098A (es) | Composiciones y usos de las mismas para el tratamiento de trastornos en el sistema nervioso central. | |
| MX2017012393A (es) | Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico. | |
| JO3530B1 (ar) | مركبات بيريدازين 1،4-ثنائية الإرتباط ونظائرها وطرق معالجة نقص smn وحالاته المرضية. | |
| MX2020011449A (es) | Oxiesteroles y metodos de uso de los mismos. | |
| MX2017007814A (es) | Compuesto de carbamoilpiridona policiclicos y su uso farmaceutico. | |
| GEP20186892B (en) | 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease | |
| MX2020011652A (es) | Derivados de piridazina 1,4-disustituida, y su uso para el tratamiento de afecciones relacionadas con la deficiencia de smn. | |
| EP4316591A3 (de) | Oxysterole und verfahren zu ihrer verwendung | |
| MX2018005041A (es) | Compuestos para tratar la esclerosis lateral amiotrofica. | |
| NZ746825A (en) | Oxysterols and methods of use thereof | |
| MX2017003517A (es) | Estimuladores de guanilato ciclasa soluble (sgc). | |
| TN2017000031A1 (en) | Imidazopyridazine compounds | |
| SG11201903801YA (en) | Pyridone compound as c-met inhibitor | |
| PH12019550154A1 (en) | Azetidine derivative | |
| WO2018039077A8 (en) | Therapeutic compounds | |
| MX2019002901A (es) | Tratamiento de esclerosis multiple con chs-131. | |
| MX2020013352A (es) | Tratamiento para migrañas. | |
| EP4335500A3 (de) | Verfahren zur synthese von deuteriertem dextromethorphan | |
| SG11201803867TA (en) | Sodium channel blocker | |
| SG11201900360TA (en) | Therapeutic agent for glaucoma | |
| PH12020500233A1 (en) | Adamantylmethylamine derivative and use thereof as pharmaceutical | |
| ZA201904033B (en) | Pharmaceutical compounds |